99 Results

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Riely
    Riely
  4. Giralt
    Giralt
  5. Abou-Alfa
    Abou-Alfa
  6. Ginsberg
    Ginsberg
  7. Kris
    Kris
  8. Postow
    Postow
  9. Shah
    Shah
  10. Tallman
    Tallman

Groups

  1. Department of Medicine (78)
  2. Solid Tumor Oncology Division (53)
  3. Hematologic Malignancies, Division of (32)
  4. Center for Hematologic Malignancies (25)
  5. Survivorship Research (20)
  6. Radiology, Department of (17)
  7. Epidemiology and Biostatistics (16)
  8. Thoracic Oncology (16)
  9. GSK Faculty (15)
  10. Biostatistics Service (13)
  1. "hypertransaminasemia"
Formats
  1. Journal Article (87)
  2. Review (10)
  3. Guidelines (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (78)
  2. Solid Tumor Oncology Division (53)
  3. Hematologic Malignancies, Division of (32)
  4. Center for Hematologic Malignancies (25)
  5. Survivorship Research (20)
  6. Radiology, Department of (17)

More Groups

People
  1. Martin Tallman (7)
  2. Alexander Drilon (6)
  3. Gregory Riely (6)
  4. Robert Motzer (6)
  5. Sergio Giralt (5)
  6. Ghassan Abou-Alfa (4)

More People

Years
  1. 2025 (9)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (10)
  5. 2021 (4)
  6. 2020 (12)

More Years

Publications
  1. Lancet Oncology (5)
  2. Leukemia and Lymphoma (5)
  3. New England Journal of Medicine (4)
  4. Annals of Oncology (3)
  5. Annals of Surgical Oncology (3)
  6. Biology of Blood and Marrow Transplantation (3)

More Publications

Publishers
  1. Elsevier Inc. (11)
  2. Springer (10)
  3. Nature Publishing Group (9)
  4. Taylor & Francis Group (9)
  5. Elsevier Science, Inc. (7)
  6. Oxford University Press (6)

More Publishers

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology
    Review

    Arora, S. P.; Liposits, G.; Caird, S.; Dunne, R. F.; Moffat, G. T.; Okonji, D.; Rodriquenz, M. G.; Dua, D.; Dotan, E.
    Journal of Geriatric Oncology (2020)

    Fulltext@MSK | Save
  • Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma
    Journal Article

    O'Reilly, E. M.; Barone, D.; Mahalingam, D.; Bekaii-Saab, T.; Shao, S. H.; Wolf, J.; Rosano, M.; Krause, S.; Richards, D. A.; Yu, K. H.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)
    Journal Article

    Lancet, J. E.; Moseley, A. B.; Coutre, S. E.; DeAngelo, D. J.; Othus, M.; Tallman, M. S.; Litzow, M. R.; Komrokji, R. S.; Erba, H. P.; Appelbaum, F. R.
    Blood Advances (2020)

    Fulltext@MSK | Save
  • TATTON: A multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
    Journal Article

    Oxnard, G. R.; Yang, J. C. H.; Yu, H.; Kim, S. W.; Saka, H.; Horn, L.; Goto, K.; Ohe, Y.; Mann, H.; Thress, K. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: Integrated analysis of three phase 1-2 trials
    Journal Article

    Drilon, A.; Siena, S.; Dziadziuszko, R.; Barlesi, F.; Krebs, M. G.; Shaw, A. T.; de Braud, F.; Rolfo, C.; Ahn, M. J.; Wolf, J.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: Integrated analysis of three phase 1-2 trials
    Journal Article

    Doebele, R. C.; Drilon, A.; Paz-Ares, L.; Siena, S.; Shaw, A. T.; Farago, A. F.; Blakely, C. M.; Seto, T.; Cho, B. C.; Tosi, D.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Regorafenib in combination with first-line chemotherapy for metastatic esophagogastric cancer
    Journal Article

    Moy, R. H.; Dos Santos Fernandes, G.; Jonsson, P.; Chou, J. F.; Basunia, A.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer
    Journal Article

    Moore, K. N.; Miller, A.; Bell-McGuinn, K. M.; Schilder, R. J.; Walker, J. L.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; Hagemann, A. R.; Gray, H. J.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
    Journal Article

    Frigault, M. J.; Armand, P.; Redd, R. A.; Jeter, E.; Merryman, R. W.; Coleman, K. C.; Herrera, A. F.; Dahi, P.; Nieto, Y.; LaCasce, A. S.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Complete response and immune-mediated adverse effects with checkpoint blockade: Treatment of mismatch repair-deficient colorectal neuroendocrine carcinoma
    Journal Article

    Whitman, J.; Kardosh, A.; Diaz, L. Jr; Fong, L.; Hope, T.; Onodera, C.; Joseph, N.; Le, D.; Fisher, G.; Bergsland, E.
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save